AQST - Aquestive gains after initial data for allergy candidate
2024-06-25 09:29:33 ET
More on Aquestive Therapeutics
- Aquestive Therapeutics, Inc. (AQST) Q1 2024 Earnings Call Transcript
- Aquestive Therapeutics, Inc. 2024 Q1 - Results - Earnings Call Presentation
- Aquestive Therapeutics: Positive Phase III Data Unlocks Additional Catalysts For 2024
- Aquestive stock falls amid Libervant approval, Anaphylm update
- Aquestive wins FDA approval for anti-seizure therapy Libervant